View Single Post
Old 08-05-2020, 09:41 PM   #1
News
Senior Member
 
News's Avatar
 
Join Date: Oct 2007
Posts: 18,905
HDAC6 inhibitors increase efficacy of immunotherapy in triple-negative breast cancer

Genetic modifier HDAC6 was found to control tumor growth and halt metastasis in triple-negative breast cancer in vivo, according to a new study published in the top-tier journal Cancer Research by investigators at the George Washington University (GW) Cancer Center.

More...
News is offline   Reply With Quote